Clinical significance in COPD patients followed in a real practice

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 5, 2013, Pages

  De Oliveira, Júlio César Mendes ^a,b   De Carvalho Aguiar, Isabella ^b   De Oliveira Beloto, Ana Carolina Negrinho ^a,b   Santos, Israel Reis ^b   Leitão Filho, Fernando Sergio Studart ^c   Sampaio, Luciana M Malosa ^b   Donner, Claudio F ^d   De Oliveira, Luís Vicente Franco ^b  

^a Institute of the Lung   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

^d Mondo Medico   (Italy)

Author keywords

COPD; Dyspnea; Smoking

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DIURETIC AGENT; FENOTEROL; FORMOTEROL; IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE; VASODILATOR AGENT;

AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; CORTICOSTEROID THERAPY; COUGHING; DISEASE EXACERBATION; DYSPNEA; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; NEUROLOGIC DISEASE; OXYGEN THERAPY; QUALITY OF LIFE; SMOKING; SPUTUM; WHEEZING;

EID: 84879954748     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-43     Document Type: Article

References (29)

1. Jemal A, Ward E, Hao YA, Thun M: Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005, 294(10):1255-1259. (Pubitemid 41352114)
2. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda: NHLBI/WHO workshop report; 2008. [updated 2013; cited 2013 03/21/2013]; Available from: www.goldcopd.com.
3. Chapman KR, Mannino DM, Soriano JB, Vermeine PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R: Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:188-207. (Pubitemid 43092683)
4. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532. (Pubitemid 44794666)
5. Menezes AM, Lopez MV, Hallal PC, Muino A, Perez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, de Oca MM, Tálamo C, Victora CG, PLATINO Team: Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health 2009, 9:151.
6. Peña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L: Geographical variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989.
7. Kim DS, Kim YS, Jung K-S, Chang JH, Lim CM, Lee JH, Uh ST, Shim JJ, Lew WJ, Korean Academy of Tuberculosis and Respiratory Diseases: revalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005, 172:842-847. (Pubitemid 41369067)
8. Wang Y-C, Lin J-M, Li C-Y, Lee LT, Guo YL, Sung FC: Prevalence and risks of chronic airway obstruction. A population cohort study. Chest 2007, 131:705-710. (Pubitemid 46446860)
9. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C: COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004, 9: 458-465. (Pubitemid 40179750)
10. Menezes AM, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG, PLATINO Team: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881. (Pubitemid 41690116)
11. Buist AS, McBurnie MA, Vollmer WM, William M, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007, 370:741-750. (Pubitemid 47321907)
12. De Miguel J, Izquierdo Alonso JL, Rodríguez G-M, de Lucas Ramos P, Molina Paris J: Tratamiento farmacológico de la EPOC en dos niveles asistenciales. Grado de adecuación a las normativas recomendadas. Arch Bronconeumol 2003, 39:195-202. (Pubitemid 36736198)
13. Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabriel R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V: Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 2005, 99:985-995. (Pubitemid 40796541)
14. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeine PA, Vestbo J: Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002, 20:799-805. (Pubitemid 35175112)
15. Roche N, Lepage T, Bourcereau J, Terrioux P: Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001, 18:903-908. (Pubitemid 34092861)
16. Jardim JR, de Oliveira JC, Nascimento O: II Consenso Brasileiro sobreDoençaPulmonarObstrutivaCrônica - DPOC. J Bras Pneumol 2004, 30(S. 5):9-41.
17. Miravitlles M, Murio C, Tirado-Conde G, Levy G, Muellerova H, Soriano JB, Ramirez-Venegas A, Ko FW, Canelos-Estrella B, Giugno E, Bergna M, Chérrez I, Anzueto A: Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis 2008, 3(4):803-814.
18. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54(7):581-586. (Pubitemid 29296676)
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. (Pubitemid 41079078)
20. Esteban C, Moraza J, Quintana JM, Aburto M, Capelastegui A: Use of medication and quality of life among patients with COPD. Respir Med 2006, 100:487-495. (Pubitemid 43239883)
21. Viejo-Banuelos JL, Pueyo-Bastida A, Fueyo-Rodriguez A: Characteristics of outpatients with COPD in daily practice: The E4 Spanish project. Respir Med 2006, 100(12):2137-2143. (Pubitemid 44718398)
22. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL: Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007, 85(7):527-534. (Pubitemid 47041631)
23. Santos SR, Goncalves MS, Leitao Filho FS, Jardim JR: Profile of smokers seeking a smoking cessation program. J Bras Pneumol 2008, 34(9):695-701.
24. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Perez-Padilla R, Jardim JR: Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res 2007, 40(7):887-895. (Pubitemid 47232872)
25. Herland K, Akselsen JP, Skjonsberg OH, Bjermer L: How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 2005, 99(1):11-19. (Pubitemid 40017378)
26. Horvathova H, Kimlikova K, Balazovjech I, Kyselovic I: Compliance and the therapeutic effect in patients with arterial hypertension. BratislLekListy 2003, 104(4-5):149-154.
27. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW: Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 2006, 8(7):706-711. (Pubitemid 44635314)
28. Schneider C, Jick SS, Bothner U, Meier CR: Chronic obstructive pulmonary disease and the risk of depression. Chest 2010, 137(2):341-347.
29. Rubinstein AL, Irazola VE, Bazanno LA, Sobrino E, Calandrelli M, Lanas F, Lee AG, Manfredi JA, Olivera H, Ponzo J, Seron P, He J: Detection and follow-up of chronic obstructive pulmonary disease (COPD) and risk factors in the Southern Cone of Latin America: the pulmonary risk in South America (PRISA) study. BMC Pulm Med 2011, 11(34):1471-1476.